Anchiano Therapeutics appoints Bob Connelly to its Board of Directors alongside Dr Steve Hoffman as Chairman
– USA, MA – Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today announced the appointments of Stephen Hoffman, M.D.,…